Research interests include Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, vaccines and immunoinformatics approaches, and Bladder and Urothelial Cancer Treatments.
Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial
Nature Medicine2023cited by 124position: middledoi
A large-scale retrospective study enabled deep-learning based pathological assessment of frozen procurement kidney biopsies to predict graft loss and guide organ utilization
Kidney International2023cited by 26position: middledoi
NKG2A and HLA-E define an alternative immune checkpoint axis in bladder cancer